MeiraGTx Quarterly Income Statement
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MeiraGTx revenue and earnings
In the quarter ended Jun 30, 2026, MeiraGTx generated $321.4 million in revenue, up 8608.6% from the same quarter a year earlier. Net income was $160.7 million, for a net margin of 50.0% versus a median of -2075.9% in the prior 5 quarters. Operating margin was 76.0%.
Diluted earnings per share came in at $1.71.
Summary generated from market data by MetaCap's automated system. Methodology
MeiraGTx income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.43M | 293.00K | 75.36M | 410.00K | 3.69M | 1.93M | 21.39M | 10.91M | 282.00K | 697.00K | 2.04M | 5.10M |
| Revenue growth (YoY) | +8608.59% | -84.79% | +252.33% | -96.24% | +1208.87% | +176.33% | +948.53% | +113.80% | -92.03% | -79.09% | — | +5.96% |
| Operating Expenses | 77.01M | 41.11M | 48.89M | 46.46M | 48.48M | 43.52M | 52.88M | 50.95M | 46.19M | 47.47M | 45.79M | 37.87M |
| Research & Development | 57.83M | 31.98M | 30.81M | 32.53M | 33.49M | 32.78M | 23.98M | 26.24M | 34.93M | 34.32M | 33.67M | 27.86M |
| Selling, General & Admin | — | 9.13M | 18.08M | 13.93M | 14.99M | 10.74M | 28.89M | 24.71M | — | — | — | — |
| Operating Income | 244.43M | -40.82M | 26.47M | -46.05M | -44.79M | -41.60M | -31.49M | -40.04M | -45.91M | -46.77M | -43.75M | -32.76M |
| Interest Expense | 3.51M | 2.85M | 3.06M | 3.06M | 3.03M | 3.04M | 3.41M | 3.36M | 3.25M | 3.25M | 3.45M | 3.38M |
| Income Tax | 2.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 160.72M | -46.31M | 15.09M | -50.51M | -38.80M | -39.98M | -39.40M | -39.33M | -48.62M | -20.44M | 20.21M | -44.30M |
| Net Income growth (YoY) | — | — | — | — | — | — | -294.90% | — | — | — | — | — |
| EPS (Basic) | 1.76 | -0.57 | 0.19 | -0.62 | -0.48 | -0.51 | -0.49 | -0.55 | -0.76 | -0.32 | 0.40 | -0.74 |
| EPS (Diluted) | 1.71 | -0.57 | 0.19 | -0.62 | -0.48 | -0.51 | -0.49 | -0.55 | -0.76 | -0.32 | 0.40 | -0.74 |
| Shares Outstanding (Basic) | 91.42M | 81.30M | — | 80.95M | 80.59M | 79.03M | — | 71.63M | 64.38M | 64.07M | — | 59.53M |
| Shares Outstanding (Diluted) | 93.81M | 81.30M | — | 80.95M | 80.59M | 79.03M | — | 71.63M | 64.38M | 64.07M | — | 59.53M |
| EBITDA | 247.25M | -37.81M | 29.59M | -42.90M | -41.60M | -38.52M | -28.42M | -36.78M | -42.69M | -43.50M | -39.84M | -29.28M |
| Operating Margin | 76.04% | -13930.72% | 35.13% | -11231.95% | -1213.57% | -2159.71% | -147.22% | -367.01% | -16279.79% | -6710.47% | -2144.80% | -642.01% |
| Net Margin | 50.00% | -15806.48% | 20.02% | -12320.24% | -1051.07% | -2075.86% | -184.19% | -360.49% | -17241.13% | -2932.86% | 990.93% | -868.06% |
This table shows 12 quarterly periods of MeiraGTx's income statement, from Q2 2026 back to Q3 2023, across 17 line items including revenue, operating expenses, research & development. Values in USD; B = billions, M = millions. Fiscal periods follow MGTX's reporting calendar. What is a income statement?